Search

Your search keyword '"Guillou, Louis"' showing total 139 results
Start Over Author "Guillou, Louis" Search Limiters Peer Reviewed
139 results on '"Guillou, Louis"'

1. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors

Author

Croce, Sabrina, Ducoulombier, Agnès, Ribeiro, Agnès, Lesluyes, Tom, Noel, Jean-Christophe, Amant, Frédéric, Guillou, Louis, Stoeckle, Eberhard, Devouassoux-Shisheboran, Mojgan, Penel, Nicolas, Floquet, Anne, Arnould, Laurent, Guyon, Frédéric, Mishellany, Florence, Chakiba, Camille, Cuppens, Tine, Zikan, Michal, Leroux, Agnès, Frouin, Eric, Farre, Isabelle, Genestie, Catherine, Valo, Isabelle, MacGrogan, Gaëtan, and Chibon, Frédéric

Published
2018
Full Text
View/download PDF

2. Drug-induced aortic valve stenosis: An under recognized entity

Author

Ennezat, Pierre-Vladimir, Bruneval, Patrick, Czitrom, Daniel, Gueffet, Jean-Pierre, Piriou, Nicolas, Trochu, Jean Noël, Patra, Odile, Blanchard-Lemoine, Bénédicte, du Fretay, Xavier Halna, Nazeyrollas, Pierre, Assoun, Bernard, Jobic, Yannick, Brochet, Eric, Bogino, Emmanuel, Roudaut, Raymond, Augier, Caroline, Greffe, Lorraine, Petit-Eisenmann, Hélène, Dambrin, Camille, Chavanon, Olivier, Guillou, Louis, Grisoli, Dominique, Morera, Pierre, Banfi, Carlo, Remadi, Jean Paul, Fabre, Olivier, Vincentelli, André, Lantuejoul, Sylvie, Ikoli, Jean-Fortuné, Copin, Marie-Christine, Malergue, Marie-Christine, Maréchaux, Sylvestre, and Tribouilloy, Christophe

Published
2016
Full Text
View/download PDF

5. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone

Author

Dujardin, Fanny, Binh, Matthieu Bui Nguyen, Bouvier, Corinne, Gomez-Brouchet, Anne, Larousserie, Frédérique, Muret, Anne de, Louis-Brennetot, Caroline, Aurias, Alain, Coindre, Jean-Michel, Guillou, Louis, Pedeutour, Florence, Duval, Hélène, Collin, Christine, and de Pinieux, Gonzague

Published
2011
Full Text
View/download PDF

27. Histologic Grade, But Not SYT-SSX Fusion Type, Is an Important Prognostic Factor in Patients With Synovial Sarcoma: A Multicenter, Retrospective Analysis

Author

Guillou, Louis, Benhattar, Jean, Bonichon, Françoise, Gallagher, Gabrielle, Terrier, Philippe, Stauffer, Edouard, de Saint Aubain Somerhausen, Nicolas, Michels, Jean-Jacques, Jundt, Gernot, Vince, Dominique Ranchère, Taylor, Sophia, Genevay, Muriel, Collin, Françoise, Trassard, Martine, and Coindre, Jean-Michel

Published
2004
Full Text
View/download PDF

35. Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: A reliable and powerful diagnostic tool for pathologists: A molecular analysis of 221 mesenchymal tumors fixed in different fixatives

Author

Guillou, Louis, Coindre, Jean-Michel, Gallagher, Gabrielle, Terrier, Philippe, Gebhard, Sandra, De Saint Aubain Somerhausen, Nicolas, Michels, Jean-Jacques, Jundt, Gernot, Vince, Dominique Ranchère, Collin, Françoise, Trassard, Martine, Le Doussal, Viviane, and Benhattar, Jean

Published
2001
Full Text
View/download PDF

49. Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients.

Author

Ling Cai, Mirimanoff, René-Olivier, Mouhsine, Elyazid, Guillou, Louis, Leyvraz, Pierre-Francois, Leyvraz, Serge, Gay, Beatrice, Matzinger, Oscar, Ozsahin, Mahmut, and Zouhair, Abderrahim

Subjects
SOFT tissue tumors, CANCER treatment, SARCOMA, ONCOLOGIC surgery, CANCER chemotherapy, RADIOTHERAPY, RETROSPECTIVE studies, TUMOR treatment
Abstract

The aim of the present study is to assess the disease profile, outcome and prognostic factors in patients treated with surgery combined with radiotherapy (RT), with or without chemotherapy (CXT), for soft-tissue sarcoma (STS) in a multidisciplinary setting. One hundred and sixty-four patients with STS treated between 1980 and 2010 at the Centre Hospitalier Universitaire Vaudois were enrolled in this retrospective study. Seventy-six percent of patients underwent postoperative RT with (24%), or without (52%) CXT, 15% preoperative RT with (5%), or without (10%) CXT, surgery alone (7%), or RT alone (2%) with or without CXT. The median follow-up was 60 months (range 6-292). Local failure was observed in 18%, and distant failure in 21% of the patients. Overall survival (OS), diseasefree survival (DFS), local control (LC) and distant metastases-free survival (DMFS) were 88%, 68%, 83%, and 79% at 5 years, and 80%, 56%, 76%, and 69% at 10 years, respectively. In univariate analyses, favorable prognostic factors for OS, DFS, and DMFS were tumor size 6 cm or less, World Health Organization (WHO)/Zubrod score 0, and stage 2 or less. Age and superficial tumors were favorable only for OS and DMFS respectively. STS involving the extremities had a better outcome regarding DFS and LC. Histological grade 2 or less was favorable for DFS, DMFS, and LC. Radical surgery was associated with better LC and DMFS. RT dose more than 60 Gy was favorable for OS, DFS, and LC. In multivariate analyses, independent factors were age for OS; tumor size for OS, DFS and DMFS; WHO/Zubrod score for OS, DFS and LC; hemoglobin level for DFS; site for DFS and LC; tumor depth for DMFS; histological grade for DFS and LC; surgical procedure for LC and DMFS; and RT dose for OS. This study confirms that in a multidisciplinary setting, STS have a fairly good prognosis. A number of prognostic and predictive factors, including the role of surgery combined with RT, were identified. Regarding RT, a dose of more than 60 Gy was associated with a better outcome, at the price of a higher toxicity. We could not demonstrate a superiority of preoperative RT over postoperative RT. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results